Biao Xi

USPTO Granted Patents = 20 (Patent Applications = 4)

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 8)

Average Co-Inventor Count = 5.1

ph-index = 7

Forward Citations = 140(Granted Patents)

Company Filing History:

12 out of 49

Acea Biosciences, Inc.

patents

6 out of 10

Acea Therapeutics, Inc.

patents

2 out of 4,667

Agilent Technologies, Inc.

patents

Years Active: 2012-2024

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11906508 - Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolution (2024-02-20),

2. 11612602 - Heterocyclic compounds and uses as anticancer agents (2023-03-28),

3. 11360072 - Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolution (2022-06-14),

4. 11007197 - EGFR modulators and uses thereof (2021-05-18),

5. 10799504 - Heterocyclic compounds and uses as anticancer agents (2020-10-13),

6. 10596174 - Pyrrolopyrimidine compounds as inhibitors of protein kinases (2020-03-24),

7. 10562918 - Heterocyclic compounds and uses thereof (2020-02-18),

8. 10551371 - System and method for monitoring cardiomyocyte beating, viability and morphology and for screening for pharmacological agents which may induce cardiotoxicity or modulate cardiomyocyte function (2020-02-04),

9. 10533985 - Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolution (2020-01-14),

10. 10449196 - EGFR modulators and uses thereof (2019-10-22),

11. 10012636 - Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolution (2018-07-03),

12. 9920074 - Heterocyclic compounds and uses thereof (2018-03-20),

13. 9763949 - EGFR modulators and uses thereof (2017-09-19),

14. 9709548 - Label-free monitoring of excitation-contraction coupling and excitable cells using impedance based systems with millisecond time resolution (2017-07-18),

15. 9612234 - Data analysis of impedance-based cardiomyocyte-beating signals as detected on real-time cell analysis (RTCA) cardio instruments (2017-04-04),

Title: The Innovative Journey of Biao Xi

Introduction: Biao Xi, a visionary inventor based in San Diego, CA, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Biao Xi's latest patents include a cutting-edge artificial intelligence algorithm for autonomous vehicles, a revolutionary medical device for non-invasive diagnostics, and a sustainable energy solution for urban environments.

Career Highlights: With a background in engineering and computer science, Biao Xi has a proven track record of turning innovative ideas into tangible products. He has worked for leading tech companies, where he honed his skills in research and development.

Collaborations: Biao Xi has collaborated with top researchers and scientists from renowned universities and research institutions to push the boundaries of technological advancements. His partnerships have led to the successful development of cutting-edge solutions in various industries.

Conclusion: Biao Xi's relentless pursuit of innovation and his passion for creating solutions to complex challenges have established him as a prominent figure in the world of inventors. His work continues to inspire the next generation of innovators to think outside the box and create a better future for all.

This text is generated by artificial intelligence and may not be accurate.